Evidence map›Paper›PMID 38559317›Full record

ArticleAmerican heart journal plus : cardiology research and practice2021

Impact of continuous positive airway pressure ventilation on cardiovascular outcomes among patients with obstructive sleep apnea: A meta-analysis of randomized trials.

Ayman Elbadawi, Islam Y Elgendy, Mina Shnoda, Ahmed S Abuzaid, Kirolos Barssoum, Mahmoud Gouda, Michael Megaly, Amit Bansal, Martha Gulati, Hani Jneid

Open access · goldAbstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Ayman ElbadawiDivision of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Islam Y ElgendyDepartment of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
Mina ShnodaDivision of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, United States of America.
Ahmed S AbuzaidDivision of Cardiology, University of California San Francisco, San Francisco, CA.
Kirolos BarssoumDepartment of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, United States of America.
Mahmoud GoudaDepartment of Internal Medicine, Conemaugh Memorial Medical Center, Johnstown, PA, United States of America.
Michael MegalyDivision of Cardiology, University of Arizona, Phoenix, United States of America.
Amit BansalDepartment of Cardiology, UHS Wilson Medical Center, Johnson City, NY, United States of America.
Martha GulatiDivision of Cardiology, University of Arizona, Phoenix, United States of America.
Hani JneidDivision of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Baylor College of Medicine · USUniversity of Arizona · USAllegheny General Hospital · USConemaugh Health System · USThe University of Texas Medical Branch at Galveston · USUnited Health Services · USUniversity of California, San Francisco · USWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The impact of continuous positive airway pressure (CPAP) on cardiovascular outcomes among patients with obstructive sleep apnea (OSA) is controversial. Objective: To evaluate the impact of CPAP on reducing cardiovascular outcomes in patients with OSA. Methods: We performed a computerized search of MEDLINE, EMBASE and COCHRANE databases through April 2021 for randomized trials evaluating the impact of CPAP versus control on cardiovascular outcomes in patients with OSA. Summary estimates were reported using both fixed and random effects model. The main study outcome was major adverse cardiac events (MACE). Results: The final analysis included 8 randomized trials with total of 5684 patients. The weighted mean follow-up was 42.6 months. There was no difference between the CPAP and control groups in the risk of MACE (14.4% versus 14.8%, risk ratio [RR]: 0.97; 95% confidence interval [CI]: 0.85 to 1.10; p = 0.60; I Conclusions and relevance: CPAP use might not be associated with lower cardiovascular events among patients with OSA. However, patients adherent to CPAP (≥4 h/night) might derive a benefit on cardiovascular outcomes. Future studies are warranted to evaluate the impact of CPAP in reducing cardiovascular events among patients with severe OSA and with optimal adherence rates to CPAP therapy.

Indexed as

Cardiovascular outcomesCPAP treatmentObstructive sleep apnea

Identifiers

PMID38559317
PMCPMC10978146
OpenAlexW3206691842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.